{"id":"W6920543020","doi":"10.60692/9fbzz-h8t81","title":"MILO/ENGOT-ov11: Binimetinib Versus Physician's Choice Chemotherapy in Recurrent or Persistent Low-Grade Serous Carcinomas of the Ovary, Fallopian Tube, or Primary Peritoneum","year":2020,"lang":"en","type":"article","venue":"Greater South Information System","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chemotherapy; Clinical endpoint; Progression-free survival; Serous fluid; Overall survival; Chemotherapy regimen; Interim analysis; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001694306,0.0006789982,0.001503945,0.000476512,0.0001963696,0.0006790765,0.0004776428,0.0008946438,0.003828584],"category_scores_gemma":[0.001412981,0.0003522849,0.000909809,0.0002719847,0.0006631355,0.0007237897,0.0003718162,0.001672406,0.0003384784],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000723507,"about_ca_system_score_gemma":0.0006509934,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005387872,"about_ca_topic_score_gemma":0.001834683,"domain_scores_codex":[0.9993204,0.0003933462,0.00004262847,0.00008886713,0.00005284389,0.0001018775],"domain_scores_gemma":[0.9992757,0.0002670841,0.0001832843,0.00004032013,0.00002206421,0.0002114496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9453111,0.00635761,0.002220846,0.0003667764,0.0004744891,0.0000304089,0.00005406455,0.0008547315,0.003500669,0.0001710621,0.0004373396,0.04022084],"study_design_scores_gemma":[0.5350092,0.4451026,0.00974384,0.0001021501,0.001085867,0.0001200297,0.0000719873,0.002923051,0.003324963,0.0004559493,0.002025822,0.00003454641],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941351,0.002385001,0.0003444107,0.0002551289,0.0001661053,0.000957813,0.0003118461,0.00005188604,0.001392539],"genre_scores_gemma":[0.996699,0.0007237096,0.0005198581,0.0002401706,0.00009247612,0.0005622527,0.0001720431,0.000005842269,0.0009846517],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003828584,"threshold_uncertainty_score":0.01280791,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06215989570715908,"score_gpt":0.2517268451583197,"score_spread":0.1895669494511606,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}